CME GROUP INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 210.9 USD | -0.75% |
|
-0.99% | +0.16% |
| Apr. 26 | Wall Street: the worst week of 2024 is followed by the best | CF |
| Apr. 26 | US Equity Indexes Advance This Week as Fed's Preferred Measure of Inflation Meets Expectations | MT |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 71,931 | 65,354 | 82,108 | 60,492 | 75,815 | 75,944 | - | - |
| Enterprise Value (EV) 1 | 74,123 | 67,064 | 82,719 | 61,210 | 76,216 | 75,766 | 76,070 | 75,947 |
| P/E ratio | 34 x | 31 x | 31.3 x | 22.7 x | 23.8 x | 22.2 x | 22 x | 20.7 x |
| Yield | 2.74% | 3.24% | 3% | 5.05% | 4.58% | 4.55% | 4.77% | 4.99% |
| Capitalization / Revenue | 14.8 x | 13.4 x | 17.5 x | 12.1 x | 13.6 x | 12.8 x | 12.4 x | 11.7 x |
| EV / Revenue | 15.2 x | 13.7 x | 17.6 x | 12.2 x | 13.7 x | 12.8 x | 12.4 x | 11.7 x |
| EV / EBITDA | 23 x | 20.8 x | 26.4 x | 18.1 x | 20.1 x | 18.4 x | 17.7 x | 16.5 x |
| EV / FCF | 30.5 x | 26.6 x | 36.4 x | 20.6 x | 22.6 x | 20.2 x | 20.2 x | 19.1 x |
| FCF Yield | 3.27% | 3.75% | 2.75% | 4.85% | 4.43% | 4.94% | 4.96% | 5.25% |
| Price to Book | 2.75 x | 2.48 x | 2.99 x | 2.25 x | 2.83 x | 2.76 x | 2.62 x | 2.36 x |
| Nbr of stocks (in thousands) | 358,364 | 358,991 | 359,399 | 359,728 | 359,993 | 360,028 | - | - |
| Reference price 2 | 200.7 | 182.0 | 228.5 | 168.2 | 210.6 | 210.9 | 210.9 | 210.9 |
| Announcement Date | 2/12/20 | 2/10/21 | 2/9/22 | 2/8/23 | 2/14/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 4,868 | 4,884 | 4,690 | 5,019 | 5,579 | 5,919 | 6,133 | 6,492 |
| EBITDA 1 | 3,217 | 3,225 | 3,128 | 3,378 | 3,786 | 4,118 | 4,292 | 4,599 |
| EBIT 1 | 3,059 | 3,082 | 2,982 | 3,243 | 3,660 | 3,951 | 4,094 | 4,402 |
| Operating Margin | 62.83% | 63.11% | 63.58% | 64.62% | 65.61% | 66.76% | 66.75% | 67.8% |
| Earnings before Tax (EBT) 1 | 2,690 | 2,722 | 3,374 | 3,490 | 4,154 | 4,742 | 4,965 | 5,355 |
| Net income 1 | 2,116 | 2,105 | 2,636 | 2,657 | 3,186 | 3,448 | 3,487 | 3,653 |
| Net margin | 43.48% | 43.11% | 56.22% | 52.94% | 57.1% | 58.25% | 56.86% | 56.26% |
| EPS 2 | 5.910 | 5.870 | 7.290 | 7.400 | 8.860 | 9.514 | 9.610 | 10.20 |
| Free Cash Flow 1 | 2,427 | 2,518 | 2,275 | 2,966 | 3,377 | 3,744 | 3,772 | 3,984 |
| FCF margin | 49.86% | 51.56% | 48.51% | 59.1% | 60.54% | 63.27% | 61.51% | 61.37% |
| FCF Conversion (EBITDA) | 75.44% | 78.07% | 72.75% | 87.8% | 89.21% | 90.93% | 87.89% | 86.63% |
| FCF Conversion (Net income) | 114.68% | 119.61% | 86.3% | 111.63% | 106.02% | 108.6% | 108.18% | 109.07% |
| Dividend per Share 2 | 5.500 | 5.900 | 6.850 | 8.500 | 9.650 | 9.597 | 10.06 | 10.54 |
| Announcement Date | 2/12/20 | 2/10/21 | 2/9/22 | 2/8/23 | 2/14/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 1,110 | 1,147 | 1,347 | 1,237 | 1,228 | 1,208 | 1,442 | 1,360 | 1,338 | 1,439 | 1,488 | 1,514 | 1,465 | 1,472 | 1,529 |
| EBITDA 1 | 734.3 | 753.9 | 955.1 | 839.8 | 828.8 | 758.9 | 1,000 | 927.9 | 908.5 | 949.5 | 1,047 | 1,070 | 1,031 | 995.5 | 1,073 |
| EBIT 1 | 697.6 | 718.3 | 921.6 | 806.8 | 795.5 | 721.3 | 968.3 | 895.6 | 877.4 | 918.8 | 1,017 | 1,009 | 962.7 | 939.7 | 1,046 |
| Operating Margin | 62.85% | 62.61% | 68.44% | 65.21% | 64.79% | 59.72% | 67.17% | 65.84% | 65.59% | 63.84% | 68.33% | 66.62% | 65.73% | 63.86% | 68.41% |
| Earnings before Tax (EBT) 1 | 1,096 | 799.3 | 916.3 | 866.7 | 880 | 827.3 | 1,157 | 1,016 | 974.3 | 1,006 | 1,113 | 1,291 | 1,160 | 1,105 | - |
| Net income 1 | 926.5 | 625.2 | 711 | 662.5 | 671.1 | 629.9 | 872.7 | 777.6 | 740.8 | 804.3 | 844.4 | 936.2 | 846.7 | 814.1 | - |
| Net margin | 83.48% | 54.49% | 52.8% | 53.55% | 54.66% | 52.15% | 60.54% | 57.17% | 55.37% | 55.88% | 56.75% | 61.84% | 57.81% | 55.32% | - |
| EPS 2 | 2.580 | 1.710 | 1.950 | 1.820 | 1.870 | 1.750 | 2.430 | 2.140 | 2.060 | 2.240 | 2.350 | 2.586 | 2.337 | 2.242 | 2.480 |
| Dividend per Share 2 | 0.9000 | 4.150 | 1.000 | 1.000 | 1.000 | 5.500 | 1.100 | 1.100 | 1.100 | 6.350 | 1.150 | 1.150 | 1.150 | 5.930 | 1.223 |
| Announcement Date | 10/27/21 | 2/9/22 | 4/27/22 | 7/27/22 | 10/26/22 | 2/8/23 | 4/26/23 | 7/26/23 | 10/25/23 | 2/14/24 | 4/24/24 | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | 2,192 | 1,710 | 610 | 718 | 402 | - | 126 | 2.58 |
| Net Cash position 1 | - | - | - | - | - | 178 | - | - |
| Leverage (Debt/EBITDA) | 0.6813 x | 0.5301 x | 0.1951 x | 0.2126 x | 0.1061 x | - | 0.0294 x | 0.000561 x |
| Free Cash Flow 1 | 2,427 | 2,518 | 2,275 | 2,966 | 3,377 | 3,745 | 3,773 | 3,984 |
| ROE (net income / shareholders' equity) | 9.35% | 9.19% | 9.82% | 10.6% | 11.9% | 13.1% | 12.8% | 13.3% |
| ROA (Net income/ Total Assets) | 3.19% | 2.41% | 1.64% | 1.54% | 2.1% | 2.36% | 2.38% | 2.5% |
| Assets 1 | 66,375 | 87,259 | 160,717 | 172,132 | 151,941 | 145,952 | 146,609 | 146,104 |
| Book Value Per Share 2 | 72.90 | 73.50 | 76.40 | 74.90 | 74.40 | 76.30 | 80.60 | 89.40 |
| Cash Flow per Share | - | 7.570 | 6.690 | 8.510 | - | - | - | - |
| Capex 1 | 246 | 198 | 127 | 89.7 | 76.4 | 93.1 | 93.5 | 98.8 |
| Capex / Sales | 5.05% | 4.04% | 2.71% | 1.79% | 1.37% | 1.57% | 1.52% | 1.52% |
| Announcement Date | 2/12/20 | 2/10/21 | 2/9/22 | 2/8/23 | 2/14/24 | - | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
210.9
USD
Average target price
226.3
USD
Spread / Average Target
+7.27%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +0.16% | 75.94B | |
| +12.06% | 21.7B | |
| +27.19% | 12.54B | |
| +39.83% | 8.36B | |
| +44.53% | 5.21B | |
| -2.16% | 2.96B | |
| +30.25% | 2.55B | |
| -5.45% | 1.69B | |
| +15.14% | 1.29B | |
| +74.10% | 1.28B |
- Stock Market
- Equities
- CME Stock
- Financials CME Group Inc.
